Improving Balance and Energetics of Walking Using a Hip Exoskeleton
Learning-based Control of a Hip Exoskeleton to Improve Balance and Energetics of Human Walking Functions
1 other identifier
interventional
100
1 country
1
Brief Summary
Robotic lower limb exoskeletons aim to improve or augment limb functions. Automatic modulation of robotic assistance is very important because it can increase the assistive outcomes and guarantee safety when using exoskeletons. However, this automatic assistance adjustment is challenging due to person-to-person and day-to-day variations, as well as the time-varying complex human-machine-interaction forces. In recent years, human-in-the-loop optimization methods have been investigated to reduce participants' metabolic costs by providing personalized assistance from robotic exoskeletons. However, metabolic cost measure is noisy and the experimental protocol is usually relatively long. In addition, the influence of exoskeleton control on this human state in terms of energetic cost is unclear and indirect. More importantly, the optimization by reducing metabolic cost is found to affect human gait patterns and cause undesired outcomes. In this study, new evaluation measures other than metabolic cost will be investigated to optimize the assistance from a powered hip exoskeleton based on a reinforcement learning method. It is hypothesized that the new reinforcement learning-based optimal control approach will produce personalized torque assistance, reduce human volitional effort, and improve balance and other performance during walking tasks. Both participants without and with neurological disorders will be included in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Jun 2022
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 28, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 20, 2023
December 1, 2023
2.6 years
June 28, 2022
December 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Human lower limb joints angular position
The investigators will measure the angular position \[rad\] on the left and right hip joints by using the embedded incremental encoders that are installed on the hip exoskeleton. The investigators will measure the angular position \[rad\] on the left and right knee and ankle joints using the motion capture system containing the 3-dimensional coordinates of reflective markers.
Through study completion, an average of 55 months.
Human lower limb joints angular velocity
The investigators will measure the angular velocity \[rad/sec\] on the left and right hip joints by using the embedded incremental encoders that are installed on the hip exoskeleton. The investigators will measure the angular velocity \[rad/sec\] on the left and right knee and ankle joints using the motion capture system containing the 3-dimensional coordinates of reflective markers. The calculation of the angular velocity is the time-derivative of the angular position in the unit of \[mm\].
Through study completion, an average of 55 months.
Secondary Outcomes (6)
Human walking stride length
Through study completion, an average of 55 months.
Human walking symmetry
Through study completion, an average of 55 months.
Human lower limb joints torque
Through study completion, an average of 55 months.
Human lower limb joints power
Through study completion, an average of 55 months.
Human lower limb muscles activity
Through study completion, an average of 55 months.
- +1 more secondary outcomes
Study Arms (2)
Group A - Participants without neurological disorders
EXPERIMENTALIndividuals without any neurological disorders will be recruited (Group A). Usually, participants from this group are able to walk normally on different terrains and at multiple typical walking speeds.
Group B - Participants with paretic stroke
EXPERIMENTALIndividuals with paretic stroke will be recruited (Group S). Usually, participants from this group have limited hip joint motion of range, weakened hip joint flexion or extension, or both flexion and extension functionalities, but they can also walk independently.
Interventions
The bilateral hip exoskeleton has two degrees of freedom to enable the hip joint extension and flexion movement on both left and right sides. The zero impedance mode will not provide any assistance or resistance to the hip joints.
The personalized optimal assistance mode includes both individualized hip flexion and hip extension assistance, which is determined by using the reinforcement learning-based automatic control parameters tuning during walking tasks. Therefore, the personalized optimal assistance will be able to improve the walking gait performance and reduce the energetic consumption.
The free walking mode will not include the usage of the wearable bilateral hip exoskeleton, and the human walking subjects will conduct pure natural walking tasks.
Eligibility Criteria
You may qualify if:
- Between 18 and 64 years old
- Live in the United States
- Able to understand study requirements and sign an informed consent
- Have full range of motion in your hip joint
- Able to walk normally without any assistance.
You may not qualify if:
- Cannot follow instructions or provide feedback due to cognitive or language limitations
- Suffered from a stroke that affects balance or walking
- Use an electronically controlled medical device, such as a pacemaker, implanted defibrillator, or drug pump
- Pregnancy
- Experience numbness, tingling, muscle weakness, pain, or paralysis in any part of your body
- Cannot walk or balance without help from a person or a tool, such as a walker or cane
- Limited movement in your hip or ankle
- You have any skin-related allergies or irritation to adhesives
- Have blood circulation, heart, metabolic, or cognitive disorders, including but not limited to: Peripheral vascular disease, Pitting edema, Heart disease, Diabetes (uncontrolled), Seizures, and Cognitive diagnoses that affect their ability to process information.
- Between 18 and 64 years old
- Live in the United States
- Able to understand study requirements and sign an informed consent
- Have weakness on one side of their body due to a stroke within the past 6 months
- Have the doctor confirm that the subjects had a stroke within the past 6 months
- Can walk without any assistance for at least 6 minutes and 1000 feet (a little less than a quarter-mile)
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Carolina State University
Raleigh, North Carolina, 27695, United States
Related Publications (3)
M. Li, Y. Wen, X. Gao, J. Si, and H. Huang, "Toward expedited impedance tuning of a robotic prosthesis for personalized gait assistance by reinforcement learning control," IEEE Trans. Robot., vol. 38, no. 1, pp. 407-420, 2022.
RESULTWen Y, Si J, Brandt A, Gao X, Huang HH. Online Reinforcement Learning Control for the Personalization of a Robotic Knee Prosthesis. IEEE Trans Cybern. 2020 Jun;50(6):2346-2356. doi: 10.1109/TCYB.2019.2890974. Epub 2019 Jan 16.
PMID: 30668514RESULTX. Tu, M. Li, M. Liu, J. Si, and H. H. Huang, "A data-driven reinforcement learning solution framework for optimal and adaptive personalization of a hip exoskeleton," in 2021 IEEE International Conference on Robotics and Automation (ICRA), 2021, pp. 10 610- 10 616.
RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jackson Family Distinguished Professor
Study Record Dates
First Submitted
June 28, 2022
First Posted
July 7, 2022
Study Start
June 1, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
December 20, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share